GlassScriptPhysician profile
Audrey S Wang
NPI 1669609681
$1,465.25
in general payments reported to CMS, 2019-2025
17 companies · $888 in 2025
The $888 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $81.21 · 2024: $496 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $420.82 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $308.90 | 2023-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $94.28 | 2025 | |
| Amgen INC. | $80.56 | 2024-2025 | Otezla, Otezla |
| Abbvie INC. | $78.55 | 2025 | |
| Genzyme Corporation | $72.65 | 2024-2025 | |
| Incyte Corporation | $56.45 | 2024-2025 | Opzelura |
| Ucb, INC. | $56.22 | 2025 | Bimzelx |
| Lilly USA, LLC | $50.34 | 2024 | Taltz, Ebglyss |
| Arcutis Biotherapeutics, INC. | $45.19 | 2025 | Zoryve |
| Helsinn Therapeutics (U.S.), INC. | $35.57 | 2025 | Valchlor |
| Janssen Biotech, INC. | $30.63 | 2025 | Tremfya |
| Leo Pharma INC. | $29.41 | 2024 | Adbry |
| Dermavant Sciences, INC. | $29.34 | 2024 | Vtama |
| Tactile Systems Technology INC | $27.63 | 2024 | Entre Plus, Flexitouch Plus |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $24.92 | 2024 | Ycanth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.79 | 2024 | Spevigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.